Huntington's disease: Neuropsychiatric manifestations of Huntington's disease

Anita My Goh1, Pierre Wibawa2, Samantha M Loi3

  • 1Neuropsychologist, Neuropsychiatry Unit, Royal Melbourne Hospital, Parkville, VIC, and; Research Fellow, Academic Unit for Psychiatry of Old Age, The University of Melbourne, Melbourne, VIC, and; National Ageing Research Institute, Parkville, VIC, Australia.

Insights

Huntington's disease (HD) management focuses on maximizing quality of life by addressing neuropsychiatric symptoms. These symptoms can appear decades before motor signs, impacting function and offering insights into neurodegeneration.

Area of Science:

  • Neurology
  • Neuroscience
  • Psychiatry

Background:

  • Huntington's disease (HD) is a fatal neurodegenerative disorder with no current cure.
  • Current management aims to improve quality of life and functional independence for patients and families.
  • Neuropsychiatric manifestations are a significant aspect of HD's clinical presentation.

Purpose of the Study:

  • To review the common neuropsychiatric manifestations in Huntington's disease.
  • To outline and evaluate the aetiology, symptoms, and diagnosis of these neuropsychiatric facets.
  • To provide clinical insights into neurodegeneration and psychiatric disorders.

Main Methods:

  • This is a clinical update review.
  • Focuses on common neuropsychiatric manifestations.
  • Outlines and evaluates various neuropsychiatric facets of HD.

Main Results:

  • Neuropsychiatric symptoms can precede motor symptoms by decades in prodromal HD.
  • These symptoms significantly impair function.
  • HD offers insights into organic psychiatric disorders and neurodegeneration.

Conclusions:

  • Neuropsychiatric symptoms are a critical, often early, feature of Huntington's disease.
  • Understanding these symptoms is key to managing HD and improving patient outcomes.
  • HD research contributes to understanding neurodegenerative processes and psychiatric manifestations.
Abstract

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Positive Symptoms of Schizophrenia: Hallucinations and Delusions01:30

Positive Symptoms of Schizophrenia: Hallucinations and Delusions

Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes loosely...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...